P2RY12 and Hypertension: After adjustment using the propensity score, as well as additional adjustment for diabetes, hypertension, peripheral vascular disease, CCI score, estimated glomerular filtration rate, and P2Y12 inhibitor use at discharge, the HR of all-cause mortality was 0.30 (95% CI, 0.16-0.56; P < .001).